SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-027393
Filing Date
2024-02-08
Accepted
2024-02-08 06:06:00
Documents
20
Period of Report
2024-02-06
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d782679d8k.htm   iXBRL 8-K 46052
2 EX-10.1 d782679dex101.htm EX-10.1 174354
3 EX-10.2 d782679dex102.htm EX-10.2 91625
4 EX-10.3 d782679dex103.htm EX-10.3 39139
5 EX-99.1 d782679dex991.htm EX-99.1 35611
9 GRAPHIC g782679g0207182603257.jpg GRAPHIC 2687
10 GRAPHIC g782679g0207182603460.jpg GRAPHIC 1412
  Complete submission text file 0001193125-24-027393.txt   613690

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA autl-20240206.xsd EX-101.SCH 2849
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE autl-20240206_lab.xml EX-101.LAB 17925
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE autl-20240206_pre.xml EX-101.PRE 11236
21 EXTRACTED XBRL INSTANCE DOCUMENT d782679d8k_htm.xml XML 3725
Mailing Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP
Business Address THE MEDIAWORKS 191 WOOD LANE LONDON X0 W12 7FP 44 20 3829 6230
Autolus Therapeutics plc (Filer) CIK: 0001730463 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38547 | Film No.: 24606708
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)